FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

39484711000001109: Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-May 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1772241000001116 Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1772251000001118 Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Is a Olanzapine 20mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has AMP Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) true Inferred relationship Existential restriction modifier
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has specific active ingredient Olanzapine true Inferred relationship Existential restriction modifier
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Olanzapine 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start